Back to DDD Stock Lookup

DDD – FDA

Apr 30, 2008 03:39 PM SCOLR Pharma (DDD) Announces Positive Progress for Lead Product
Apr 17, 2007 08:41 AM SCOLR Pharma (DDD) Announces Positive Ibuprofen Study Results and Status of Commercialization Program
Feb 6, 2007 03:05 PM SCOLR Pharma (DDD) Announces Positive Results from Its Second 24 Hour CDT-Ondansetron Trial; Discontinues Development of Extended Release Phenylephrine
Mar 28, 2005 09:10 AM DDD Reports Positive Initial Clinical Results for CDT-Pseudoephedrine
Mar 1, 2005 09:19 AM DDD Announces the Start of its Extended Release CDT-Pseudoephedrine Human Trials
Jan 24, 2005 11:01 PM DDD said FDA to permit U.S. testing of its 12-hour ER ibuprofen tablets

Back to DDD Stock Lookup